1/1
2 files

AN OPEN LETTER TO THE SCIENTIFIC COMMUNITY ON THE POSSIBLE ROLE OF DYSREGULATED BRADYKININ SIGNALING IN COVID-19 RESPIRATORY COMPLICATIONS

journal contribution
posted on 16.04.2020, 04:41 by Joseph Roche, Renuka Roche
In this Open Letter to the Scientific Community, we propose a model for dysregulated bradykinin signaling in COVID-19 respiratory complications. Based on our model, we suggest the off-label and compassionate use of the FDA-approved bradykinin receptor blocker, icatibant, for patients with unremitting respiratory distress from COVID-19.

Funding

None

History

Licence

Exports

Licence

Exports